4.7 Article

α-Aryl-N-alkyl Nitrones, as Potential Agents for Stroke Treatment: Synthesis, Theoretical Calculations, Antioxidant, Anti-inflammatory, Neuroprotective, and Brain-Blood Barrier Permeability Properties

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 1, Pages 153-168

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm201105a

Keywords

-

Funding

  1. MICINN [SAF2006-08764-C02-01, SAF2009-07271, CTQ2009-10478, SAF2009-11219, SAF2010-20337, RETICS-RD06/0026/008, SAF2006-01249, SAF2009-13015-C02-01]
  2. Comunidad de Madrid [S/SAL-0275-2006]
  3. ISCIII [Retic RENEVAS (RD06/0026/012)]
  4. UCM-Santander [GR35/10-B]
  5. Institute of Health Carlos III (ISCIII) [FIS08/0761]

Ask authors/readers for more resources

We report the synthesis, theoretical calculations, the antioxidant, anti-inflammatory, and neuroprotective properties, and the ability to cross the blood-brain barrier (BBB) of (Z)-alpha-aryl and heteroaryl-N-alkyl nitrones as potential agents for stroke treatment. The majority of nitrones compete with DMSO for hydroxyl radicals, and most of them are potent lipoxygenase inhibitors. Cell viability-related (MTT assay) studies clearly showed that nitrones 1-3 and 10 give rise to significant neuroprotection. When compounds 1-11 were tested for necrotic cell death (LDH release test) nitrones 1-3, 6, 7, and 9 proved to be neuroprotective agents. In vitro evaluation of the BBB penetration of selected nitrones 1, 2, 10, and 11 using the PAMPA-BBB assay showed that all of them cross the BBB. Permeable quinoline nitrones 2 and 3 show potent combined antioxidant and neuroprotective properties and, therefore, can be considered is new lead compounds for further development in specific tests for potential stroke treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

Antinociceptive and modulatory effect of pathoplastic changes in spinal glia of a TLR4/CD14 blocking molecule in two models of pain in rat

Miguel M. Garcia, Miguel Molina-Alvarez, Carmen Rodriguez-Rivera, Nancy Paniagua, Ernesto Quesada, Jose Antonio Uranga, Maria Isabel Rodriguez-Franco, David Pascual, Carlos Goicoechea

Summary: Spinal glia plays a crucial role in the development and maintenance of chronic pain. The TLR4 signaling pathway is identified as a key trigger mechanism in pain. By using a CD14/TLR4 antagonist, researchers explored the effects of TLR4 inhibition on pain development and glia activation in different pain models. Their findings suggest that peripheral and central TLR4 have different roles in diverse types of pain.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Biochemistry & Molecular Biology

Nucleobase-Derived Nitrones: Synthesis and Antioxidant and Neuroprotective Activities in an In Vitro Model of Ischemia-Reperfusion

Beatriz Chamorro, Iwona E. Gtowacka, Joanna Gotkowska, Rafal Gulej, Dimitra Hadjipavlou-Litina, Francisco Lopez-Munoz, Jose Marco-Contelles, Dorota G. Piotrowska, Maria Jesus Oset-Gasque

Summary: This study reports the synthesis, antioxidant, and neuroprotective properties of nucleobase-derived nitrones against an ischemia model. The nitrones with purine and pyrimidine nucleobases showed better neuroprotective effects, while the introduction of methyl or halogen substituents may decrease their neuroprotective activity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Multidisciplinary

Synthesis and biological applications of some novel 8-Hydroxyquinoline urea and thiourea derivatives

Mohammad A. Khasawneh, Ayesha AlKaabi, Abdelouahid Samadi, Priya Antony, Ranjit Vijayan, Lamya Ahmed Al-Keridis, Haythem A. Saadeh, Nael Abutaha

Summary: A series of novel urea and thiourea derivatives of 8-hydroxyquinoline were designed, synthesized, and evaluated for their anticancer activities. The structures of the new compounds were determined using spectroscopic techniques, and their cytotoxicity against breast cancer cell lines was assessed. Molecular docking studies revealed potential interactions between these compounds and proteins associated with breast cancer.

ARABIAN JOURNAL OF CHEMISTRY (2022)

Article Pharmacology & Pharmacy

Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid

Valeria Kopytina, Lucia Pascual-Anton, Nora Toggweiler, Eva-Maria Arriero-Pais, Lisa Strahl, Patricia Albar-Vizcaino, David Sucunza, Juan J. Vaquero, Sonja Steppan, Dorothea Piecha, Manuel Lopez-Cabrera, Guadalupe-Tirma Gonzalez-Mateo

Summary: This study analyzed the biocompatibility of Steviol glycosides (SG)-based fluids compared to glucose-based fluids and evaluated their impact on the peritoneal membrane. The results showed that SG-based fluids have better ability to protect and maintain the functionality of the peritoneal membrane compared to glucose-based fluids.

FRONTIERS IN PHARMACOLOGY (2022)

Review Chemistry, Medicinal

KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

Enrique Crisman, Pablo Duarte, Esteban Dauden, Antonio Cuadrado, Maria Isabel Rodriguez-Franco, Manuela G. Lopez, Rafael Leon

Summary: The translation discusses the importance of the transcription factor NRF2 in the antioxidant response and its association with various diseases. The article also explores the innovative strategy of discovering NRF2 activators through KEAP1-NRF2 protein-protein interaction inhibitors and summarizes the known inhibitors and their design features, as well as the preclinical pharmacological properties of these compounds.

MEDICINAL RESEARCH REVIEWS (2023)

Article Chemistry, Medicinal

8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin?s antidepressant profile: Synthesis, biological evaluation and docking studies

Maria J. Matos, Paula Novo, Lucia Mayan, Iria Torres, Eugenio Uriarte, Matilde Yanez, Jose Angel Fontenla, Francesco Ortuso, Stefano Alcaro, Francesca Procopio, Maria Isabel Rodriguez-Franco, Cristina Val, Maria I. Loza, Jose Brea, Fernanda Borges, Dolores Vina

Summary: Psychiatric and neurological disorders affect millions of people worldwide, and current treatments are limited in their effectiveness. New therapeutic solutions are urgently needed to improve the lives of patients.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Pharmacology & Pharmacy

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases

Damijan Knez, Daniel Diez-Iriepa, Mourad Chioua, Andrea Gottinger, Milica Denic, Fabien Chantegreil, Florian Nachon, Xavier Brazzolotto, Anna Skrzypczak-Wiercioch, Anze Meden, Anja Pislar, Janko Kos, Simon Zakelj, Jure Stojan, Kinga Salat, Julia Serrano, Ana Patricia Fernandez, Aitana Sanchez-Garcia, Ricardo Martinez-Murillo, Claudia Binda, Francisco Lopez-Munoz, Stanislav Gobec, Jose Marco-Contelles

Summary: This study describes the development of quinolylnitrones (QNs) as multifunctional ligands inhibiting cholinesterases and monoamine oxidases for the therapy of neurodegenerative diseases.

ACTA PHARMACEUTICA SINICA B (2023)

Article Multidisciplinary Sciences

Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models

Beatriz Chamorro, Sara Izquierdo-Bermejo, Julia Serrano, Dimitra Hadjipavlou-Litina, Mourad Chioua, Francisco Lopez-Munoz, Jose Marco-Contelles, Ricardo Martinez-Murillo, Maria Jesus Oset-Gasque

Summary: Cerebral ischemia is a growing global problem and the leading cause of disability. Researchers have focused on finding neuroprotective drugs that target the molecular processes involved in cerebral ischemia. Six new quinolylnitrones (QNs) have been discovered, which show promising neuroprotective and antioxidant properties against ischemia-reperfusion in neuronal cultures. Among these QNs, QN6 demonstrates the highest antioxidant power and neuroprotective effect, making it a potential candidate for cerebral ischemia therapy.

SCIENTIFIC REPORTS (2023)

Article Chemistry, Medicinal

Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase

Umberto Maria Battisti, Leticia Monjas, Fady Akladios, Josipa Matic, Eric Andresen, Carolin H. Nagel, Malin Hagkvist, Liliana Haversen, Woonghee Kim, Mathias Uhlen, Jan Boren, Adil Mardinoglu, Morten Grotli

Summary: The inhibition of liver pyruvate kinase is a potential strategy for treating or reversing non-alcoholic fatty liver disease (NAFLD). Urolithin C has been identified as a promising scaffold for developing allosteric inhibitors of liver pyruvate kinase. A comprehensive structure-activity analysis of urolithin C and its analogues was conducted, revealing important chemical features for the desired activity. These findings may facilitate the discovery of more potent and selective PKL allosteric inhibitors.

PHARMACEUTICALS (2023)

Article Chemistry, Organic

1,2,3-Benzotriazine Synthesis by Heterocyclization of p-Tosylmethyl Isocyanide Derivatives

Francisco Maqueda-Zelaya, Jose Luis Acena, Estibaliz Merino, Juan J. Vaquero, David Sucunza

Summary: An efficient methodology has been developed for the synthesis of 4-alkoxy- and 4-aryloxybenzo[d][1,2,3]triazines via an intramolecular heterocyclization of 1-azido-2-[isocyano(p-tosyl)methyl]benzenes under basic conditions. DFT calculations were performed to gain a better understanding of the mechanism behind this heterocyclization, which demonstrated good to excellent yields with a broad scope.

JOURNAL OF ORGANIC CHEMISTRY (2023)

Article Polymer Science

Novel Grafted Hydrogel for Iron and Ammonia Removal from Groundwater: A Synthesis and Computational Chemistry Study

H. M. Abd El-Salam, Ali M. El Shafey, Abdelouahid Samadi, Mahmoud K. Abdel-Latif

Summary: Current research focuses on the removal of iron and ammonia from groundwater using a poly acrylic-poly acrylamide hydrogel grafted with 3-chloroaniline. The effects of agitation time, dosage, and adsorbent temperature on the removal process sensitivity were investigated. The hydrogel showed efficient regeneration and selective removal of iron and ammonia.
Article Chemistry, Medicinal

Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors

Sandra Codony, Jose M. Entrena, Carla Calvo-Tusell, Beatrice Jora, Rafael Gonzalez-Cano, Silvia Osuna, Ruben Corpas, Christophe Morisseau, Belen Perez, Marta Barniol-Xicota, Christian Grinan-Ferre, Concepcion Perez, Maria Isabel Rodriguez-Franco, Anton L. Martinez, M. Isabel Loza, Merce Pallas, Steven H. L. Verhelst, Coral Sanfeliu, Ferran Feixas, Bruce D. Hammock, Jose Brea, Enrique J. Cobos, Santiago Vazquez

Summary: A new benzohomoadamantane-based sEH inhibitor has been developed to improve the drug metabolism and pharmacokinetics properties for pain-related disorders, showing anti-allodynic and analgesic effects in murine models of capsaicin-induced allodynia and cyclophosphamide-induced cystitis.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents

Tim Keuler, Carina Lemke, Paul W. Elsinghorst, Isabel Iriepa, Mourad Chioua, Maria Angeles Martinez-Grau, Christopher D. Beadle, Tatiana Vetman, Francisco Lopez-Munoz, Timo Wille, Ulrike Bartz, Winnie Deuther-Conrad, Jose Marco-Contelles, Michael Guetschow

Summary: The multifactorial nature of Alzheimer's disease requires the development of drugs that can target different relevant pathways. In this study, we synthesized a series of tailored chromanones and identified compound 19 as a representative compound with balanced pharmacological properties. Compound 19 showed inhibitory activities against human acetyl- and butyrylcholinesterase, monoamine oxidase-B, and high affinity to sigma 1 and sigma 2 receptors.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)

Article Chemistry, Medicinal

The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents

Tim Keuler, Carina Lemke, Paul W. Elsinghorst, Isabel Iriepa, Mourad Chioua, Maria Angeles Martinez-Grau, Christopher D. Beadle, Tatiana Vetman, Francisco Lopez-Munoz, Timo Wille, Ulrike Bartz, Winnie Deuther-Conrad, Jose Marco-Contelles, Michael Gutschow

Summary: The multifactorial nature of Alzheimer's disease necessitates the development of agents that can target multiple relevant pathways. In this study, we synthesized a series of tailored chromanones and evaluated their biological activities. One representative compound (compound 19) was identified, which exhibited balanced pharmacological properties and showed inhibitory activities against acetylcholinesterase, butyrylcholinesterase, monoamine oxidase-B, and high affinity to sigma 1 and sigma 2 receptors. Our findings provide a framework for the development of chromanone-based multineurotarget agents.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)

No Data Available